Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja Wiethoff

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Olanzapine in the treatment of depression with psychotic features: A prospective open-label studyMazda Adli, Katja Wiethoff, Christopher Baethge, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 23, 2013
Pretreatment anterior cingulate activity predicts antidepressant treatment response in major depressive episodesJohannes Rentzsch, Mazda Adli, Katja Wiethoff, et al.
Biological Psychiatry|July 14, 2007
Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphismMazda Adli, Dorothea L Hollinde, Thomas Stamm, et al.
Journal of Affective Disorders|July 16, 2011
Algorithm-guided treatment of depression reduces treatment costs--results from the randomized controlled German Algorithm Project (GAPII)Roland Ricken, Katja Wiethoff, Thomas Reinhold, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm ProjectKatja Wiethoff, Michael Bauer, Thomas C Baghai, et al.
Journal of Psychopharmacology (Oxford, England)|December 10, 2015
The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depressionThomas J Stamm, Carina Rampp, Katja Wiethoff, et al.
Journal of Affective Disorders|December 19, 2017
A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3)Roland Ricken, Katja Wiethoff, Thomas Reinhold, et al.
Journal of Affective Disorders|December 3, 2014
Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disordersStephan Köhler, Katja Wiethoff, Roland Ricken, et al.
The International Journal of Neuropsychopharmacology|June 25, 2017
How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 TrialMazda Adli, Katja Wiethoff, Thomas C Baghai, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Olanzapine in the treatment of depression with psychotic features: A prospective open-label studyMazda Adli, Katja Wiethoff, Christopher Baethge, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 23, 2013
Pretreatment anterior cingulate activity predicts antidepressant treatment response in major depressive episodesJohannes Rentzsch, Mazda Adli, Katja Wiethoff, et al.
Biological Psychiatry|July 14, 2007
Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphismMazda Adli, Dorothea L Hollinde, Thomas Stamm, et al.
Journal of Affective Disorders|July 16, 2011
Algorithm-guided treatment of depression reduces treatment costs--results from the randomized controlled German Algorithm Project (GAPII)Roland Ricken, Katja Wiethoff, Thomas Reinhold, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm ProjectKatja Wiethoff, Michael Bauer, Thomas C Baghai, et al.
Journal of Psychopharmacology (Oxford, England)|December 10, 2015
The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depressionThomas J Stamm, Carina Rampp, Katja Wiethoff, et al.
Journal of Affective Disorders|December 19, 2017
A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3)Roland Ricken, Katja Wiethoff, Thomas Reinhold, et al.
Journal of Affective Disorders|December 3, 2014
Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disordersStephan Köhler, Katja Wiethoff, Roland Ricken, et al.
The International Journal of Neuropsychopharmacology|June 25, 2017
How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 TrialMazda Adli, Katja Wiethoff, Thomas C Baghai, et al.
Pageof 1